Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Research involving GLP-3R peptide examines its activity across GLP-1, GIP, and glucagon receptor pathways, allowing for the study of coordinated receptor signaling and pathway interaction
You still need a prescription, and the savings apply when you pay cash rather than through insurance
2019;39(5):NP156-NP158
AstraZeneca Bristol Myers Squibb Novartis Sanofi Others Key Target Audience Market Players Investors End-users Government Authorities Consulting And Research Firm Venture capitalists Value-Added Resellers (VARs) Recent Developments In February 2023, the European Commission approved a label extension for Kerendia (finerenone) in the European Union (EU) to include results on cardiovascular (CV) outcomes from the Phase III FIGARO-DKD study
Lancet 372 , 12401250 (2008)
US$ 21.63
US$ 28.06
US$ 28.47
US$ 20.85
